E
ZyVersa Therapeutics, Inc. ZVSA
$0.7899 -$0.0111-1.39%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2024 06/30/2024 03/31/2024 12/31/2023 09/30/2023
Net Income 76.20% 75.86% -601.11% -596.03% -685.30%
Total Depreciation and Amortization -178.10% 75.00% 0.00% 0.00% 1,116.35%
Total Amortization of Deferred Charges -- -- -- -- -100.00%
Total Other Non-Cash Items -83.04% -83.18% 8,570.02% 2,365.52% 1,616.65%
Change in Net Operating Assets -108.01% -104.96% -46.03% -54.03% -6.72%
Cash from Operations 6.38% -2.37% 13.14% -78.39% -474.99%
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -- -- --
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -39.64% -2.51% -- -- --
Repurchase of Common Stock 100.00% 100.00% -- -- --
Issuance of Preferred Stock -- -- -- -- -61.23%
Repurchase of Preferred Stock 100.00% 97.80% -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 53.82% 24.25% -2,115.12% -2,344.60% -2,756.01%
Cash from Financing 261.16% 1,764.02% 502.71% 219.30% 56.95%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 80.90% 98.74% 109.85% 8.55% -2,128.30%
Weiss Ratings